PE20181375A1 - Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano - Google Patents
Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decanoInfo
- Publication number
- PE20181375A1 PE20181375A1 PE2018001302A PE2018001302A PE20181375A1 PE 20181375 A1 PE20181375 A1 PE 20181375A1 PE 2018001302 A PE2018001302 A PE 2018001302A PE 2018001302 A PE2018001302 A PE 2018001302A PE 20181375 A1 PE20181375 A1 PE 20181375A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- methyl
- diaza
- spiro
- oxo
- Prior art date
Links
- ZAJNGDIORYACQU-UHFFFAOYSA-N decan-2-one Chemical compound CCCCCCCCC(C)=O ZAJNGDIORYACQU-UHFFFAOYSA-N 0.000 abstract 4
- -1 CYCLOBUTYL-METHYL Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000003840 Opioid Receptors Human genes 0.000 abstract 1
- 108090000137 Opioid Receptors Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE 3-((HETERO)ARIL)-ALQUIL-8-AMINO-2-OXO-1,3-DIAZA-ESPIRO-[4.5]-DECANO DE FORMULA (I) DONDE n ES DE 1 A 3; R1 Y R2 SON CADA UNO -H, ALQUILO C1-C6 OPCIONALMENTE SUSTITUIDO, CICLOALQUILO C3-C12 OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R3 ES ALQUILO C1-C6, CICLOALQUILO C3-C12, ENTRE OTROS; R4 ES H, ALQUILO C1-C6, ENTRE OTROS; R5 ES ARILO C6-C14 O HETEROARILO DE 5 A 14 MIEMBROS; R7, R8, R11, R12, R13, R14, R15, R16, R17, R18, R19 Y R20 SON CADA UNO -H, -F, -Cl, -Br, -I, -OH, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: CIS-1-(CICLOBUTIL-METIL)-8-DIMETILAMINO-3-[(4-METILSULFONIL-FENIL)-METIL]-8-FENIL-1,3-DIAZAESPIRO[4.5]DECAN-2-ONA; CIS-1-(CICLOBUTIL-METIL)-8-DIMETILAMINO-3-[(3-METOXIFENIL)-METIL]-8-FENIL-1,3-DIAZAESPIRO[4.5]DECAN-2-ONA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DE RECEPTORES OPIOIDES SIENDO UTILES EN EL TRATAMIENTO DEL DOLOR
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16151013 | 2016-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20181375A1 true PE20181375A1 (es) | 2018-08-28 |
Family
ID=55129634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2018001302A PE20181375A1 (es) | 2016-01-13 | 2017-01-13 | Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US20170197947A1 (es) |
| EP (1) | EP3402784B1 (es) |
| JP (1) | JP6893517B2 (es) |
| KR (1) | KR20180098369A (es) |
| CN (1) | CN108602777B (es) |
| AR (1) | AR107360A1 (es) |
| AU (1) | AU2017206909B2 (es) |
| BR (1) | BR112018014303B1 (es) |
| CA (1) | CA3011177A1 (es) |
| CL (1) | CL2018001912A1 (es) |
| CO (1) | CO2018008444A2 (es) |
| CY (1) | CY1122818T1 (es) |
| DK (1) | DK3402784T3 (es) |
| EA (1) | EA037481B1 (es) |
| EC (1) | ECSP18060848A (es) |
| ES (1) | ES2797904T3 (es) |
| HR (1) | HRP20200837T1 (es) |
| HU (1) | HUE049813T2 (es) |
| IL (1) | IL260491B (es) |
| LT (1) | LT3402784T (es) |
| MX (1) | MX378994B (es) |
| PE (1) | PE20181375A1 (es) |
| PL (1) | PL3402784T3 (es) |
| PT (1) | PT3402784T (es) |
| RS (1) | RS60315B1 (es) |
| SI (1) | SI3402784T1 (es) |
| TW (1) | TWI636048B (es) |
| WO (1) | WO2017121648A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3402785B1 (en) | 2016-01-13 | 2020-02-26 | Grünenthal GmbH | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
| EA037649B1 (ru) | 2016-01-13 | 2021-04-27 | Грюненталь Гмбх | Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана |
| PE20181375A1 (es) | 2016-01-13 | 2018-08-28 | Gruenenthal Chemie | Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano |
| DK3402782T3 (da) | 2016-01-13 | 2020-09-28 | Gruenenthal Gmbh | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decanderivater |
| PL3722284T3 (pl) * | 2016-01-13 | 2025-03-31 | Grünenthal GmbH | Pochodne 3-((hetero-)arylo)-8-amino-2-okso-1,3-diazaspiro-[4.5]-dekanu |
| JP7256823B2 (ja) | 2018-04-18 | 2023-04-12 | コンステレーション・ファーマシューティカルズ・インコーポレイテッド | メチル修飾酵素のモジュレーター、その組成物および使用 |
| WO2019226491A1 (en) | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| AU2020207591B2 (en) | 2019-01-11 | 2024-12-05 | Grünenthal GmbH | Substituted pyrrolidine amides III |
| GB201905721D0 (en) | 2019-04-24 | 2019-06-05 | Univ Dundee | Compounds |
| AU2023419893A1 (en) * | 2022-12-28 | 2025-07-03 | Gilgamesh Pharmaceuticals, Inc. | Synthesis of 2-phenyl-2-amino-cyclohexan-1-one derivatives |
| US20240400537A1 (en) | 2023-04-25 | 2024-12-05 | Gruenenthal Gmbh | Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2734265B1 (fr) | 1995-05-17 | 1997-06-13 | Adir | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant |
| EP1997818A3 (en) | 2001-04-18 | 2009-04-08 | Euro-Celtique S.A. | Quinolinone derivatives and their use to treat pain |
| DE10130020A1 (de) | 2001-06-25 | 2003-12-04 | Gruenenthal Gmbh | Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate |
| DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
| EA009789B1 (ru) | 2002-07-05 | 2008-04-28 | Таргасепт, Инк. | N-арилдиазаспирациклические соединения и способы их получения и применения |
| DE10252667A1 (de) | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| EP1628978A2 (en) | 2003-05-23 | 2006-03-01 | Zealand Pharma A/S | Triaza-spiro compounds as nociceptin analogues and uses thereof |
| JO2676B1 (en) | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
| JP5079011B2 (ja) | 2006-10-19 | 2012-11-21 | エフ．ホフマン−ラ ロシュ アーゲー | 糖尿病のための１１β−ＨＳＤ１阻害剤としてのイミダゾロン及びイミダゾリジノン誘導体 |
| EP2150552B1 (en) | 2007-04-09 | 2013-01-02 | Janssen Pharmaceutica NV | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
| US20090247530A1 (en) * | 2008-03-27 | 2009-10-01 | Grunenthal Gmbh | Substituted 4-aminocyclohexane derivatives |
| US8268853B2 (en) | 2009-06-25 | 2012-09-18 | Abbott Laboratories | 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof |
| TWI582092B (zh) | 2010-07-28 | 2017-05-11 | 歌林達股份有限公司 | 順式－四氫－螺旋（環己烷－１,１’－吡啶［３,４－b］吲哚）－４－胺－衍生物 |
| WO2014106238A1 (en) * | 2012-12-31 | 2014-07-03 | Fang, Qun, Kevin | Heterocyclic compounds and methods of use thereof |
| US10131666B2 (en) | 2014-06-13 | 2018-11-20 | Purdue Pharma L.P. | Heterocyclic morphinan derivatives and use thereof |
| EA037649B1 (ru) | 2016-01-13 | 2021-04-27 | Грюненталь Гмбх | Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана |
| MY195199A (en) | 2016-01-13 | 2023-01-11 | Novo Nordisk As | EGF(A) Analogues with Fatty Acid Substituents |
| PE20181375A1 (es) | 2016-01-13 | 2018-08-28 | Gruenenthal Chemie | Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano |
| TWI730032B (zh) | 2016-01-13 | 2021-06-11 | 美商必治妥美雅史谷比公司 | 作為ｒｏｃｋ抑制劑之螺庚烷水楊酸醯胺及相關化合物 |
| EP3402785B1 (en) | 2016-01-13 | 2020-02-26 | Grünenthal GmbH | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
| DK3402782T3 (da) | 2016-01-13 | 2020-09-28 | Gruenenthal Gmbh | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decanderivater |
| PL3722284T3 (pl) * | 2016-01-13 | 2025-03-31 | Grünenthal GmbH | Pochodne 3-((hetero-)arylo)-8-amino-2-okso-1,3-diazaspiro-[4.5]-dekanu |
-
2017
- 2017-01-13 PE PE2018001302A patent/PE20181375A1/es unknown
- 2017-01-13 US US15/405,896 patent/US20170197947A1/en not_active Abandoned
- 2017-01-13 JP JP2018536484A patent/JP6893517B2/ja active Active
- 2017-01-13 BR BR112018014303-0A patent/BR112018014303B1/pt active IP Right Grant
- 2017-01-13 DK DK17701638.3T patent/DK3402784T3/da active
- 2017-01-13 CA CA3011177A patent/CA3011177A1/en active Pending
- 2017-01-13 WO PCT/EP2017/025006 patent/WO2017121648A1/en not_active Application Discontinuation
- 2017-01-13 HR HRP20200837TT patent/HRP20200837T1/hr unknown
- 2017-01-13 PT PT177016383T patent/PT3402784T/pt unknown
- 2017-01-13 SI SI201730268T patent/SI3402784T1/sl unknown
- 2017-01-13 RS RS20200585A patent/RS60315B1/sr unknown
- 2017-01-13 ES ES17701638T patent/ES2797904T3/es active Active
- 2017-01-13 PL PL17701638T patent/PL3402784T3/pl unknown
- 2017-01-13 MX MX2018008644A patent/MX378994B/es unknown
- 2017-01-13 EP EP17701638.3A patent/EP3402784B1/en active Active
- 2017-01-13 HU HUE17701638A patent/HUE049813T2/hu unknown
- 2017-01-13 KR KR1020187021562A patent/KR20180098369A/ko active Pending
- 2017-01-13 AR ARP170100095A patent/AR107360A1/es unknown
- 2017-01-13 AU AU2017206909A patent/AU2017206909B2/en not_active Ceased
- 2017-01-13 LT LTEP17701638.3T patent/LT3402784T/lt unknown
- 2017-01-13 TW TW106101125A patent/TWI636048B/zh active
- 2017-01-13 EA EA201891609A patent/EA037481B1/ru unknown
- 2017-01-13 CN CN201780006494.6A patent/CN108602777B/zh active Active
-
2018
- 2018-05-21 US US15/984,919 patent/US20180327392A1/en not_active Abandoned
- 2018-07-09 IL IL260491A patent/IL260491B/en unknown
- 2018-07-13 CL CL2018001912A patent/CL2018001912A1/es unknown
- 2018-08-13 EC ECSENADI201860848A patent/ECSP18060848A/es unknown
- 2018-08-13 CO CONC2018/0008444A patent/CO2018008444A2/es unknown
-
2019
- 2019-02-01 US US16/265,080 patent/US10829480B2/en active Active
-
2020
- 2020-05-04 CY CY20201100402T patent/CY1122818T1/el unknown
- 2020-08-31 US US17/007,258 patent/US20200399252A1/en not_active Abandoned
-
2021
- 2021-03-01 US US17/188,743 patent/US20210179592A1/en not_active Abandoned
-
2023
- 2023-01-30 US US18/103,180 patent/US20230174520A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20181375A1 (es) | Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano | |
| PE20190709A1 (es) | Derivado de pirazolopiridinaque tiene el efecto agonista del receptor de glp-1 | |
| PE20220567A1 (es) | Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| PE20190653A1 (es) | Nuevos derivados de pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| PE20141352A1 (es) | Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento | |
| AR077935A1 (es) | Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina | |
| PE20170666A1 (es) | 2-(morfolin-4-il)-1,7-naftiridinas | |
| PE20160844A1 (es) | Compuestos triciclicos como agentes anticancerigenos | |
| PE20120833A1 (es) | Compuestos sustituidos de espiro-amida | |
| PE20191495A1 (es) | Piridonamidas como moduladores de canales de sodio | |
| PE20090276A1 (es) | Compuestos derivados de imidazoquinolina como moduladores de tlr7 | |
| PE20160608A1 (es) | Compuestos de quinolina selectivamente sustituida | |
| PE20120561A1 (es) | Compuestos que modulan selectivamente el receptor cb2 | |
| PE20140011A1 (es) | Compuestos y composiciones novedosos para la inhibicion de nampt | |
| PE20181024A1 (es) | Derivados de ciclohexano sustituido con amido | |
| AR060237A1 (es) | Compuesto de 3-azabiciclo[3.1.0]hexano como moduladores del receptor de dopamina d3, su uso para la preparacion de un medicamento para el tratamiento de afecciones psicoticas y composicion farmaceutica que lo comprende. | |
| PE20090957A1 (es) | Moduladores de gamma secretasa | |
| EA200870196A1 (ru) | Индолсульфонамидные модуляторы рецепторов прогестерона | |
| AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
| AR074543A1 (es) | Derivados de imidazo[1,2-a]piridin-2-il, agonistas de receptores 1-fosfato de esfingosina(1s1p1), composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos en el tratamiento de enfermedades autoinmunes | |
| PE20170127A1 (es) | Indazol-3-carboxamidas 5-sustituidas y preparacion y uso de las mismas | |
| AR083831A1 (es) | Antagonistas del receptor del cgrp de piperidinona carboxamida azaindano | |
| PE20141682A1 (es) | Derivados de (4-fenilimidazol-2-il) etilamina utiles como moduladores de canal de sodio | |
| DE602006018152D1 (de) | Triazolderivate als modulatoren von dopamin-d3-rezeptoren | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal |